Seeking Alpha

Merck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that...

Merck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that proposals to put "additional price controls on drugs" could "take away much of the incentive in the capital markets to invest in research and development." The Democrats have proposed reducing soaring medical costs by using Medicare to negotiate lower drug prices.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs